APO Research
Talk to an analyst

APO RESEARCH · REPORT

Recombinant Human Thrombin Protein

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Recombinant Human Thrombin Protein Industry Growth and Trends Forecast to 2032

27 December 2025109 pages

Choose your research edition.

Industry ResearchRecombinant Human Thrombin Protein Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Recombinant Human Thrombin Protein Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Recombinant Human Thrombin Protein Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Recombinant Human Thrombin Protein Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Recombinant Human Thrombin Protein Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Recombinant Human Thrombin Protein market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Recombinant Human Thrombin Protein is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Recombinant Human Thrombin Protein is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Recombinant Human Thrombin Protein is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Recombinant Human Thrombin Protein include Takeda, Grifols, Pfizer, Bayer, Shanghai RAAS, Omrix Biopharmaceuticals, Octapharma, Hualan Biological and Haematologic Technologies, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Recombinant Human Thrombin Protein market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Recombinant Human Thrombin Protein market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Recombinant Human Thrombin Protein market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Recombinant Human Thrombin Protein.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Recombinant Human Thrombin Protein market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Recombinant Human Thrombin Protein Market by Company

Takeda

Grifols

Pfizer

Bayer

Shanghai RAAS

Omrix Biopharmaceuticals

Octapharma

Hualan Biological

Haematologic Technologies

GE Healthcare

CSL

Recombinant Human Thrombin Protein Segment by Type

Based Bovine

Based Human

Others

Recombinant Human Thrombin Protein Segment by Application

Hospitals

Clinics

Academic and Research Institute

Recombinant Human Thrombin Protein Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Recombinant Human Thrombin Protein market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Recombinant Human Thrombin Protein and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Recombinant Human Thrombin Protein.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Recombinant Human Thrombin Protein manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Recombinant Human Thrombin Protein in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Based Bovine Table 2. Major Company of Based Human Table 3. Major Company of Others Table 4. Global Recombinant Human Thrombin Protein Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Recombinant Human Thrombin Protein Sales by Type (2021-2026) & (K Units) Table 6. Global Recombinant Human Thrombin Protein Sales Market Share in Volume by Type (2021-2026) Table 7. Global Recombinant Human Thrombin Protein Sales by Type (2021-2026) & (US$ Million) Table 8. Global Recombinant Human Thrombin Protein Sales Market Share in Value by Type (2021-2026) Table 9. Global Recombinant Human Thrombin Protein Price by Type (2021-2026) & (US$/Unit) Table 10. Global Recombinant Human Thrombin Protein Sales by Type (2027-2032) & (K Units) Table 11. Global Recombinant Human Thrombin Protein Sales Market Share in Volume by Type (2027-2032) Table 12. Global Recombinant Human Thrombin Protein Sales by Type (2027-2032) & (US$ Million) Table 13. Global Recombinant Human Thrombin Protein Sales Market Share in Value by Type (2027-2032) Table 14. Global Recombinant Human Thrombin Protein Price by Type (2027-2032) & (US$/Unit) Table 15. North America Recombinant Human Thrombin Protein Sales by Type (2021-2026) & (K Units) Table 16. North America Recombinant Human Thrombin Protein Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Recombinant Human Thrombin Protein Sales by Type (2021-2026) & (K Units) Table 18. Europe Recombinant Human Thrombin Protein Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Recombinant Human Thrombin Protein Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Recombinant Human Thrombin Protein Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Recombinant Human Thrombin Protein Sales by Type (2021-2026) & (K Units) Table 22. Latin America Recombinant Human Thrombin Protein Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Recombinant Human Thrombin Protein Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Recombinant Human Thrombin Protein Sales by Type (2021-2026) & (US$ Million) Table 25. Recombinant Human Thrombin Protein Industry Trends Table 26. Recombinant Human Thrombin Protein Industry Drivers Table 27. Recombinant Human Thrombin Protein Industry Opportunities and Challenges Table 28. Recombinant Human Thrombin Protein Industry Restraints Table 29. Global Recombinant Human Thrombin Protein Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Recombinant Human Thrombin Protein Revenue Market Share by Company (2021-2026) Table 31. Global Recombinant Human Thrombin Protein Sales by Company (2021-2026) & (K Units) Table 32. Global Recombinant Human Thrombin Protein Sales Share by Company (2021-2026) Table 33. Global Recombinant Human Thrombin Protein Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Recombinant Human Thrombin Protein Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Recombinant Human Thrombin Protein Major Company Production Sites and Headquarters Table 36. Global Recombinant Human Thrombin Protein Company, Product Type & Application Table 37. Global Recombinant Human Thrombin Protein Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Recombinant Human Thrombin Protein by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Recombinant Human Thrombin Protein Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Recombinant Human Thrombin Protein Sales by Region (2021-2026) & (K Units) Table 42. Global Recombinant Human Thrombin Protein Sales Market Share in Volume by Region (2021-2026) Table 43. Global Recombinant Human Thrombin Protein Sales by Region (2021-2026) & (US$ Million) Table 44. Global Recombinant Human Thrombin Protein Sales Market Share in Value by Region (2021-2026) Table 45. Global Recombinant Human Thrombin Protein Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Recombinant Human Thrombin Protein Sales by Region (2027-2032) & (K Units) Table 47. Global Recombinant Human Thrombin Protein Sales Market Share in Volume by Region (2027-2032) Table 48. Global Recombinant Human Thrombin Protein Sales by Region (2027-2032) & (US$ Million) Table 49. Global Recombinant Human Thrombin Protein Sales Market Share in Value by Region (2027-2032) Table 50. Global Recombinant Human Thrombin Protein Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Recombinant Human Thrombin Protein Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Recombinant Human Thrombin Protein Sales by Application (2021-2026) & (K Units) Table 53. Global Recombinant Human Thrombin Protein Sales Market Share in Volume by Application (2021-2026) Table 54. Global Recombinant Human Thrombin Protein Sales by Application (2021-2026) & (US$ Million) Table 55. Global Recombinant Human Thrombin Protein Sales Market Share in Value by Application (2021-2026) Table 56. Global Recombinant Human Thrombin Protein Price by Application (2021-2026) & (US$/Unit) Table 57. Global Recombinant Human Thrombin Protein Sales by Application (2027-2032) & (K Units) Table 58. Global Recombinant Human Thrombin Protein Sales Market Share in Volume by Application (2027-2032) Table 59. Global Recombinant Human Thrombin Protein Sales by Application (2027-2032) & (US$ Million) Table 60. Global Recombinant Human Thrombin Protein Sales Market Share in Value by Application (2027-2032) Table 61. Global Recombinant Human Thrombin Protein Price by Application (2027-2032) & (US$/Unit) Table 62. North America Recombinant Human Thrombin Protein Sales by Application (2021-2026) & (K Units) Table 63. North America Recombinant Human Thrombin Protein Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Recombinant Human Thrombin Protein Sales by Application (2021-2026) & (K Units) Table 65. Europe Recombinant Human Thrombin Protein Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Recombinant Human Thrombin Protein Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Recombinant Human Thrombin Protein Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Recombinant Human Thrombin Protein Sales by Application (2021-2026) & (K Units) Table 69. Latin America Recombinant Human Thrombin Protein Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Recombinant Human Thrombin Protein Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Recombinant Human Thrombin Protein Sales by Application (2021-2026) & (US$ Million) Table 72. Takeda Company Information Table 73. Takeda Business Overview Table 74. Takeda Recombinant Human Thrombin Protein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Takeda Recombinant Human Thrombin Protein Product Portfolio Table 76. Takeda Recent Development Table 77. Grifols Company Information Table 78. Grifols Business Overview Table 79. Grifols Recombinant Human Thrombin Protein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Grifols Recombinant Human Thrombin Protein Product Portfolio Table 81. Grifols Recent Development Table 82. Pfizer Company Information Table 83. Pfizer Business Overview Table 84. Pfizer Recombinant Human Thrombin Protein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Pfizer Recombinant Human Thrombin Protein Product Portfolio Table 86. Pfizer Recent Development Table 87. Bayer Company Information Table 88. Bayer Business Overview Table 89. Bayer Recombinant Human Thrombin Protein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Bayer Recombinant Human Thrombin Protein Product Portfolio Table 91. Bayer Recent Development Table 92. Shanghai RAAS Company Information Table 93. Shanghai RAAS Business Overview Table 94. Shanghai RAAS Recombinant Human Thrombin Protein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Shanghai RAAS Recombinant Human Thrombin Protein Product Portfolio Table 96. Shanghai RAAS Recent Development Table 97. Omrix Biopharmaceuticals Company Information Table 98. Omrix Biopharmaceuticals Business Overview Table 99. Omrix Biopharmaceuticals Recombinant Human Thrombin Protein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Omrix Biopharmaceuticals Recombinant Human Thrombin Protein Product Portfolio Table 101. Omrix Biopharmaceuticals Recent Development Table 102. Octapharma Company Information Table 103. Octapharma Business Overview Table 104. Octapharma Recombinant Human Thrombin Protein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Octapharma Recombinant Human Thrombin Protein Product Portfolio Table 106. Octapharma Recent Development Table 107. Hualan Biological Company Information Table 108. Hualan Biological Business Overview Table 109. Hualan Biological Recombinant Human Thrombin Protein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Hualan Biological Recombinant Human Thrombin Protein Product Portfolio Table 111. Hualan Biological Recent Development Table 112. Haematologic Technologies Company Information Table 113. Haematologic Technologies Business Overview Table 114. Haematologic Technologies Recombinant Human Thrombin Protein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Haematologic Technologies Recombinant Human Thrombin Protein Product Portfolio Table 116. Haematologic Technologies Recent Development Table 117. GE Healthcare Company Information Table 118. GE Healthcare Business Overview Table 119. GE Healthcare Recombinant Human Thrombin Protein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. GE Healthcare Recombinant Human Thrombin Protein Product Portfolio Table 121. GE Healthcare Recent Development Table 122. CSL Company Information Table 123. CSL Business Overview Table 124. CSL Recombinant Human Thrombin Protein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. CSL Recombinant Human Thrombin Protein Product Portfolio Table 126. CSL Recent Development Table 127. North America Recombinant Human Thrombin Protein Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 128. North America Recombinant Human Thrombin Protein Sales by Country (2021-2026) & (K Units) Table 129. North America Recombinant Human Thrombin Protein Sales Market Share by Country (2021-2026) Table 130. North America Recombinant Human Thrombin Protein Sales Forecast by Country (2027-2032) & (K Units) Table 131. North America Recombinant Human Thrombin Protein Sales Market Share Forecast by Country (2027-2032) Table 132. North America Recombinant Human Thrombin Protein Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 133. North America Recombinant Human Thrombin Protein Market Size by Country (2021-2026) & (US$ Million) Table 134. North America Recombinant Human Thrombin Protein Market Share by Country (2021-2026) Table 135. North America Recombinant Human Thrombin Protein Market Size Forecast by Country (2027-2032) & (US$ Million) Table 136. North America Recombinant Human Thrombin Protein Market Share Forecast by Country (2027-2032) Table 137. Europe Recombinant Human Thrombin Protein Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 138. Europe Recombinant Human Thrombin Protein Sales by Country (2021-2026) & (K Units) Table 139. Europe Recombinant Human Thrombin Protein Sales Market Share by Country (2021-2026) Table 140. Europe Recombinant Human Thrombin Protein Sales Forecast by Country (2027-2032) & (K Units) Table 141. Europe Recombinant Human Thrombin Protein Sales Market Share Forecast by Country (2027-2032) Table 142. Europe Recombinant Human Thrombin Protein Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. Europe Recombinant Human Thrombin Protein Market Size by Country (2021-2026) & (US$ Million) Table 144. Europe Recombinant Human Thrombin Protein Market Share by Country (2021-2026) Table 145. Europe Recombinant Human Thrombin Protein Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. Europe Recombinant Human Thrombin Protein Market Share Forecast by Country (2027-2032) Table 147. Asia-Pacific Recombinant Human Thrombin Protein Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 148. Asia-Pacific Recombinant Human Thrombin Protein Sales by Country (2021-2026) & (K Units) Table 149. Asia-Pacific Recombinant Human Thrombin Protein Sales Market Share by Country (2021-2026) Table 150. Asia-Pacific Recombinant Human Thrombin Protein Sales Forecast by Country (2027-2032) & (K Units) Table 151. Asia-Pacific Recombinant Human Thrombin Protein Sales Market Share Forecast by Country (2027-2032) Table 152. Asia-Pacific Recombinant Human Thrombin Protein Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. Asia-Pacific Recombinant Human Thrombin Protein Market Size by Country (2021-2026) & (US$ Million) Table 154. Asia-Pacific Recombinant Human Thrombin Protein Market Share by Country (2021-2026) Table 155. Asia-Pacific Recombinant Human Thrombin Protein Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. Asia-Pacific Recombinant Human Thrombin Protein Market Share Forecast by Country (2027-2032) Table 157. Latin America Recombinant Human Thrombin Protein Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 158. Latin America Recombinant Human Thrombin Protein Sales by Country (2021-2026) & (K Units) Table 159. Latin America Recombinant Human Thrombin Protein Sales Market Share by Country (2021-2026) Table 160. Latin America Recombinant Human Thrombin Protein Sales Forecast by Country (2027-2032) & (K Units) Table 161. Latin America Recombinant Human Thrombin Protein Sales Market Share Forecast by Country (2027-2032) Table 162. Latin America Recombinant Human Thrombin Protein Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 163. Latin America Recombinant Human Thrombin Protein Market Size by Country (2021-2026) & (US$ Million) Table 164. Latin America Recombinant Human Thrombin Protein Market Share by Country (2021-2026) Table 165. Latin America Recombinant Human Thrombin Protein Market Size Forecast by Country (2027-2032) & (US$ Million) Table 166. Latin America Recombinant Human Thrombin Protein Market Share Forecast by Country (2027-2032) Table 167. Middle East and Africa Recombinant Human Thrombin Protein Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 168. Middle East and Africa Recombinant Human Thrombin Protein Sales by Country (2021-2026) & (K Units) Table 169. Middle East and Africa Recombinant Human Thrombin Protein Sales Market Share by Country (2021-2026) Table 170. Middle East and Africa Recombinant Human Thrombin Protein Sales Forecast by Country (2027-2032) & (K Units) Table 171. Middle East and Africa Recombinant Human Thrombin Protein Sales Market Share Forecast by Country (2027-2032) Table 172. Middle East and Africa Recombinant Human Thrombin Protein Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 173. Middle East and Africa Recombinant Human Thrombin Protein Market Size by Country (2021-2026) & (US$ Million) Table 174. Middle East and Africa Recombinant Human Thrombin Protein Market Share by Country (2021-2026) Table 175. Middle East and Africa Recombinant Human Thrombin Protein Market Size Forecast by Country (2027-2032) & (US$ Million) Table 176. Middle East and Africa Recombinant Human Thrombin Protein Market Share Forecast by Country (2027-2032) Table 177. Key Raw Materials Table 178. Raw Materials Key Suppliers Table 179. Recombinant Human Thrombin Protein Distributors List Table 180. Recombinant Human Thrombin Protein Customers List Table 181. Research Programs/Design for This Report Table 182. Authors List of This Report Table 183. Secondary Sources Table 184. Primary Sources List of Figures Figure 1. Recombinant Human Thrombin Protein Image Figure 2. Global Recombinant Human Thrombin Protein Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Recombinant Human Thrombin Protein Market Size (2021-2032) & (US$ Million) Figure 4. Global Recombinant Human Thrombin Protein Sales (2021-2032) & (K Units) Figure 5. Based Bovine Image Figure 6. Global Based Bovine Sales YoY Growth (2021-2032) & (K Units) Figure 7. Based Human Image Figure 8. Global Based Human Sales YoY Growth (2021-2032) & (K Units) Figure 9. Others Image Figure 10. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Recombinant Human Thrombin Protein Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Recombinant Human Thrombin Protein Market Share by Type 2025 VS 2032 Figure 13. North America Recombinant Human Thrombin Protein Sales Market Share in Volume by Type in 2025 Figure 14. North America Recombinant Human Thrombin Protein Sales Market Share in Value by Type in 2025 Figure 15. Europe Recombinant Human Thrombin Protein Sales Market Share in Volume by Type in 2025 Figure 16. Europe Recombinant Human Thrombin Protein Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Recombinant Human Thrombin Protein Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Recombinant Human Thrombin Protein Sales Market Share in Value by Type in 2025 Figure 19. Latin America Recombinant Human Thrombin Protein Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Recombinant Human Thrombin Protein Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Recombinant Human Thrombin Protein Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Recombinant Human Thrombin Protein Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Recombinant Human Thrombin Protein Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Hospitals Image Figure 26. Global Hospitals Sales YoY Growth (2021-2032) & (K Units) Figure 27. Clinics Image Figure 28. Global Clinics Sales YoY Growth (2021-2032) & (K Units) Figure 29. Academic and Research Institute Image Figure 30. Global Academic and Research Institute Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Recombinant Human Thrombin Protein Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Recombinant Human Thrombin Protein Market Share by Application 2025 VS 2032 Figure 33. North America Recombinant Human Thrombin Protein Sales Market Share in Volume by Application in 2025 Figure 34. North America Recombinant Human Thrombin Protein Sales Market Share in Value by Application in 2025 Figure 35. Europe Recombinant Human Thrombin Protein Sales Market Share in Volume by Application in 2025 Figure 36. Europe Recombinant Human Thrombin Protein Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Recombinant Human Thrombin Protein Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Recombinant Human Thrombin Protein Sales Market Share in Value by Application in 2025 Figure 39. Latin America Recombinant Human Thrombin Protein Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Recombinant Human Thrombin Protein Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Recombinant Human Thrombin Protein Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Recombinant Human Thrombin Protein Sales Market Share in Value by Application in 2025 Figure 43. North America Recombinant Human Thrombin Protein Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Recombinant Human Thrombin Protein Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Recombinant Human Thrombin Protein Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Recombinant Human Thrombin Protein Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Recombinant Human Thrombin Protein Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Recombinant Human Thrombin Protein Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Recombinant Human Thrombin Protein Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Recombinant Human Thrombin Protein Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Recombinant Human Thrombin Protein Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Recombinant Human Thrombin Protein Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Recombinant Human Thrombin Protein Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Recombinant Human Thrombin Protein Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Recombinant Human Thrombin Protein Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Recombinant Human Thrombin Protein Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Recombinant Human Thrombin Protein Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Recombinant Human Thrombin Protein Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Recombinant Human Thrombin Protein Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Recombinant Human Thrombin Protein Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Recombinant Human Thrombin Protein Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Recombinant Human Thrombin Protein Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Recombinant Human Thrombin Protein Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Recombinant Human Thrombin Protein Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Based Bovine
  • Based Human
  • Others
Applications
  • Hospitals
  • Clinics
  • Academic and Research Institute
Companies covered
  • Takeda
  • Grifols
  • Pfizer
  • Bayer
  • Shanghai RAAS
  • Omrix Biopharmaceuticals
  • Octapharma
  • Hualan Biological
  • Haematologic Technologies
  • GE Healthcare
  • CSL

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Recombinant Human Thrombin Protein Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Recombinant Human Thrombin Protein Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Recombinant Human Thrombin Protein Market by Type
  6. 1.3.1 Based Bovine
  7. 1.3.2 Based Human
  8. 1.3.3 Others
  9. 1.4 Global Recombinant Human Thrombin Protein Market Size by Type
  10. 1.4.1 Global Recombinant Human Thrombin Protein Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Recombinant Human Thrombin Protein Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Recombinant Human Thrombin Protein Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Recombinant Human Thrombin Protein Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Recombinant Human Thrombin Protein Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Recombinant Human Thrombin Protein Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Recombinant Human Thrombin Protein Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Recombinant Human Thrombin Protein Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Recombinant Human Thrombin Protein Industry Trends
  2. 2.2 Recombinant Human Thrombin Protein Industry Drivers
  3. 2.3 Recombinant Human Thrombin Protein Industry Opportunities and Challenges
  4. 2.4 Recombinant Human Thrombin Protein Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Recombinant Human Thrombin Protein Revenue (2021-2026)
  2. 3.2 Global Top Players by Recombinant Human Thrombin Protein Sales (2021-2026)
  3. 3.3 Global Top Players by Recombinant Human Thrombin Protein Price (2021-2026)
  4. 3.4 Global Recombinant Human Thrombin Protein Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Recombinant Human Thrombin Protein Major Company Production Sites & Headquarters
  6. 3.6 Global Recombinant Human Thrombin Protein Company, Product Type & Application
  7. 3.7 Global Recombinant Human Thrombin Protein Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Recombinant Human Thrombin Protein Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Recombinant Human Thrombin Protein Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Recombinant Human Thrombin Protein Tier 1, Tier 2, and Tier 3
4 Recombinant Human Thrombin Protein Regional Status and Outlook
  1. 4.1 Global Recombinant Human Thrombin Protein Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Recombinant Human Thrombin Protein Historic Market Size by Region
  3. 4.2.1 Global Recombinant Human Thrombin Protein Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Recombinant Human Thrombin Protein Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Recombinant Human Thrombin Protein Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Recombinant Human Thrombin Protein Forecasted Market Size by Region
  7. 4.3.1 Global Recombinant Human Thrombin Protein Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Recombinant Human Thrombin Protein Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Recombinant Human Thrombin Protein Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Recombinant Human Thrombin Protein by Application
  1. 5.1 Recombinant Human Thrombin Protein Market by Application
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinics
  4. 5.1.3 Academic and Research Institute
  5. 5.2 Global Recombinant Human Thrombin Protein Market Size by Application
  6. 5.2.1 Global Recombinant Human Thrombin Protein Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Recombinant Human Thrombin Protein Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Recombinant Human Thrombin Protein Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Recombinant Human Thrombin Protein Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Recombinant Human Thrombin Protein Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Recombinant Human Thrombin Protein Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Recombinant Human Thrombin Protein Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Recombinant Human Thrombin Protein Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Takeda
  2. 6.1.1 Takeda Company Information
  3. 6.1.2 Takeda Business Overview
  4. 6.1.3 Takeda Recombinant Human Thrombin Protein Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Takeda Recombinant Human Thrombin Protein Product Portfolio
  6. 6.1.5 Takeda Recent Developments
  7. 6.2 Grifols
  8. 6.2.1 Grifols Company Information
  9. 6.2.2 Grifols Business Overview
  10. 6.2.3 Grifols Recombinant Human Thrombin Protein Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Grifols Recombinant Human Thrombin Protein Product Portfolio
  12. 6.2.5 Grifols Recent Developments
  13. 6.3 Pfizer
  14. 6.3.1 Pfizer Company Information
  15. 6.3.2 Pfizer Business Overview
  16. 6.3.3 Pfizer Recombinant Human Thrombin Protein Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Pfizer Recombinant Human Thrombin Protein Product Portfolio
  18. 6.3.5 Pfizer Recent Developments
  19. 6.4 Bayer
  20. 6.4.1 Bayer Company Information
  21. 6.4.2 Bayer Business Overview
  22. 6.4.3 Bayer Recombinant Human Thrombin Protein Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Bayer Recombinant Human Thrombin Protein Product Portfolio
  24. 6.4.5 Bayer Recent Developments
  25. 6.5 Shanghai RAAS
  26. 6.5.1 Shanghai RAAS Company Information
  27. 6.5.2 Shanghai RAAS Business Overview
  28. 6.5.3 Shanghai RAAS Recombinant Human Thrombin Protein Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Shanghai RAAS Recombinant Human Thrombin Protein Product Portfolio
  30. 6.5.5 Shanghai RAAS Recent Developments
  31. 6.6 Omrix Biopharmaceuticals
  32. 6.6.1 Omrix Biopharmaceuticals Company Information
  33. 6.6.2 Omrix Biopharmaceuticals Business Overview
  34. 6.6.3 Omrix Biopharmaceuticals Recombinant Human Thrombin Protein Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Omrix Biopharmaceuticals Recombinant Human Thrombin Protein Product Portfolio
  36. 6.6.5 Omrix Biopharmaceuticals Recent Developments
  37. 6.7 Octapharma
  38. 6.7.1 Octapharma Company Information
  39. 6.7.2 Octapharma Business Overview
  40. 6.7.3 Octapharma Recombinant Human Thrombin Protein Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Octapharma Recombinant Human Thrombin Protein Product Portfolio
  42. 6.7.5 Octapharma Recent Developments
  43. 6.8 Hualan Biological
  44. 6.8.1 Hualan Biological Company Information
  45. 6.8.2 Hualan Biological Business Overview
  46. 6.8.3 Hualan Biological Recombinant Human Thrombin Protein Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Hualan Biological Recombinant Human Thrombin Protein Product Portfolio
  48. 6.8.5 Hualan Biological Recent Developments
  49. 6.9 Haematologic Technologies
  50. 6.9.1 Haematologic Technologies Company Information
  51. 6.9.2 Haematologic Technologies Business Overview
  52. 6.9.3 Haematologic Technologies Recombinant Human Thrombin Protein Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Haematologic Technologies Recombinant Human Thrombin Protein Product Portfolio
  54. 6.9.5 Haematologic Technologies Recent Developments
  55. 6.10 GE Healthcare
  56. 6.10.1 GE Healthcare Company Information
  57. 6.10.2 GE Healthcare Business Overview
  58. 6.10.3 GE Healthcare Recombinant Human Thrombin Protein Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 GE Healthcare Recombinant Human Thrombin Protein Product Portfolio
  60. 6.10.5 GE Healthcare Recent Developments
  61. 6.11 CSL
  62. 6.11.1 CSL Company Information
  63. 6.11.2 CSL Business Overview
  64. 6.11.3 CSL Recombinant Human Thrombin Protein Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 CSL Recombinant Human Thrombin Protein Product Portfolio
  66. 6.11.5 CSL Recent Developments
7 North America by Country
  1. 7.1 North America Recombinant Human Thrombin Protein Sales by Country
  2. 7.1.1 North America Recombinant Human Thrombin Protein Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Recombinant Human Thrombin Protein Sales by Country (2021-2026)
  4. 7.1.3 North America Recombinant Human Thrombin Protein Sales Forecast by Country (2027-2032)
  5. 7.2 North America Recombinant Human Thrombin Protein Market Size by Country
  6. 7.2.1 North America Recombinant Human Thrombin Protein Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Recombinant Human Thrombin Protein Market Size by Country (2021-2026)
  8. 7.2.3 North America Recombinant Human Thrombin Protein Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Recombinant Human Thrombin Protein Sales by Country
  2. 8.1.1 Europe Recombinant Human Thrombin Protein Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Recombinant Human Thrombin Protein Sales by Country (2021-2026)
  4. 8.1.3 Europe Recombinant Human Thrombin Protein Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Recombinant Human Thrombin Protein Market Size by Country
  6. 8.2.1 Europe Recombinant Human Thrombin Protein Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Recombinant Human Thrombin Protein Market Size by Country (2021-2026)
  8. 8.2.3 Europe Recombinant Human Thrombin Protein Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Recombinant Human Thrombin Protein Sales by Country
  2. 9.1.1 Asia-Pacific Recombinant Human Thrombin Protein Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Recombinant Human Thrombin Protein Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Recombinant Human Thrombin Protein Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Recombinant Human Thrombin Protein Market Size by Country
  6. 9.2.1 Asia-Pacific Recombinant Human Thrombin Protein Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Recombinant Human Thrombin Protein Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Recombinant Human Thrombin Protein Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Recombinant Human Thrombin Protein Sales by Country
  2. 10.1.1 South America Recombinant Human Thrombin Protein Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Recombinant Human Thrombin Protein Sales by Country (2021-2026)
  4. 10.1.3 South America Recombinant Human Thrombin Protein Sales Forecast by Country (2027-2032)
  5. 10.2 South America Recombinant Human Thrombin Protein Market Size by Country
  6. 10.2.1 South America Recombinant Human Thrombin Protein Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Recombinant Human Thrombin Protein Market Size by Country (2021-2026)
  8. 10.2.3 South America Recombinant Human Thrombin Protein Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Recombinant Human Thrombin Protein Sales by Country
  2. 11.1.1 Middle East and Africa Recombinant Human Thrombin Protein Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Recombinant Human Thrombin Protein Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Recombinant Human Thrombin Protein Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Recombinant Human Thrombin Protein Market Size by Country
  6. 11.2.1 Middle East and Africa Recombinant Human Thrombin Protein Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Recombinant Human Thrombin Protein Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Recombinant Human Thrombin Protein Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Recombinant Human Thrombin Protein Value Chain Analysis
  2. 12.1.1 Recombinant Human Thrombin Protein Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Recombinant Human Thrombin Protein Production Mode & Process
  7. 12.2 Recombinant Human Thrombin Protein Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Recombinant Human Thrombin Protein Distributors
  10. 12.2.3 Recombinant Human Thrombin Protein Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst